Total Equity - Mayne Pharma Group Ltd (ASX:MYX) - Alpha Spread

Watchlist Manager

Watchlist

Price: 5.04 AUD 0.4%

Updated:

Mayne Pharma Group Ltd
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Mayne Pharma Group Ltd
Total Equity Peer Comparison

NEU

BOT

PBP

C

CU6

ALA

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Mayne Pharma Group Ltd ASX:MYX	Total Equity AU$634.4m	CAGR 3-Years -15%	CAGR 5-Years -12%	CAGR 10-Years N/A
	Neuren Pharmaceuticals Ltd ASX:NEU	Total Equity AU$205.2m	CAGR 3-Years 104%	CAGR 5-Years 53%	CAGR 10-Years 24%
	Botanix Pharmaceuticals Ltd ASX:BOT	Total Equity AU$45.4m	CAGR 3-Years 22%	CAGR 5-Years 30%	CAGR 10-Years N/A
	Probiotec Ltd ASX:PBP	Total Equity AU$88.3m	CAGR 3-Years 10%	CAGR 5-Years 10%	CAGR 10-Years 3%
C	Clarity Pharmaceuticals Ltd ASX:CU6	Total Equity AU$69.2m	CAGR 3-Years 104%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Arovella Therapeutics Ltd ASX:ALA	Total Equity AU$3.8m	CAGR 3-Years -3%	CAGR 5-Years -20%	CAGR 10-Years N/A

See Also

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Total Equity amounts to 634.4m AUD.

Over the last year, the Total Equity growth was 16%. The average annual Total Equity growth rates for Mayne Pharma Group Ltd have been -15% over the past three years , -12% over the past five years .

Join more than 143,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.